Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review
- PMID: 12837716
- DOI: 10.1001/jama.290.1.86
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review
Abstract
Context: As more interventions become available for the treatment of coronary heart disease (CHD), policy makers and health practitioners need to understand the benefits of each intervention, to better determine where to focus resources. This is particularly true when a patient with CHD quits smoking.
Objective: To conduct a systematic review to determine the magnitude of risk reduction achieved by smoking cessation in patients with CHD.
Data sources: Nine electronic databases were searched from start of database to April 2003, supplemented by cross-checking references, contact with experts, and with large international cohort studies (identified by the Prospective Studies Collaboration).
Study selection: Prospective cohort studies of patients who were diagnosed with CHD were included if they reported all-cause mortality and had at least 2 years of follow-up. Smoking status had to be measured after CHD diagnosis to ascertain quitting.
Data extraction: Two reviewers independently assessed studies to determine eligibility, quality assessment of studies, and results, and independently carried out data extraction using a prepiloted, standardized form.
Data synthesis: From the literature search, 665 publications were screened and 20 studies were included. Results showed a 36% reduction in crude relative risk (RR) of mortality for patients with CHD who quit compared with those who continued smoking (RR, 0.64; 95% confidence interval [CI], 0.58-0.71). Results from individual studies did not vary greatly despite many differences in patient characteristics, such as age, sex, type of CHD, and the years in which studies took place. Adjusted risk estimates did not differ substantially from crude estimates. Many studies did not adequately address quality issues, such as control of confounding, and misclassification of smoking status. However, restriction to 6 higher-quality studies had little effect on the estimate (RR, 0.71; 95% CI, 0.65-0.77). Few studies included large numbers of elderly persons, women, ethnic minorities, or patients from developing countries.
Conclusions: Quitting smoking is associated with a substantial reduction in risk of all-cause mortality among patients with CHD. This risk reduction appears to be consistent regardless of age, sex, index cardiac event, country, and year of study commencement.
Comment in
-
Passive smoke exposure and risk of death from coronary heart disease.JAMA. 2003 Oct 1;290(13):1708; author reply 1708-9. doi: 10.1001/jama.290.13.1708-a. JAMA. 2003. PMID: 14519702 No abstract available.
Similar articles
-
WITHDRAWN: Smoking cessation for the secondary prevention of coronary heart disease.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD003041. doi: 10.1002/14651858.CD003041.pub3. Cochrane Database Syst Rev. 2012. PMID: 22336785 Free PMC article. Review.
-
Screening and Interventions for Childhood Overweight [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. PMID: 20722132 Free Books & Documents. Review.
-
Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis.Ann Behav Med. 2006 Aug;32(1):10-20. doi: 10.1207/s15324796abm3201_2. Ann Behav Med. 2006. PMID: 16827625 Review.
-
Smoking cessation for the secondary prevention of coronary heart disease.Cochrane Database Syst Rev. 2004;(1):CD003041. doi: 10.1002/14651858.CD003041.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003041. doi: 10.1002/14651858.CD003041.pub3. PMID: 14974003 Updated. Review.
-
Smoking cessation for the secondary prevention of coronary heart disease.Cochrane Database Syst Rev. 2003;(4):CD003041. doi: 10.1002/14651858.CD003041. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2004;(1):CD003041. doi: 10.1002/14651858.CD003041.pub2. PMID: 14583958 Updated. Review.
Cited by
-
The Differential Impact of Medical Therapy and Lifestyle Modification on Cardiovascular Health and Risk of Adverse Cardiovascular Events: A Narrative Review.Cureus. 2024 Apr 6;16(4):e57742. doi: 10.7759/cureus.57742. eCollection 2024 Apr. Cureus. 2024. PMID: 38716006 Free PMC article. Review.
-
Effects of Electronic Cigarette Vaping on Cardiac and Vascular Function, and Post-myocardial Infarction Remodeling in Rats.Cardiovasc Toxicol. 2024 Feb;24(2):199-208. doi: 10.1007/s12012-024-09835-8. Epub 2024 Feb 10. Cardiovasc Toxicol. 2024. PMID: 38340234 Free PMC article.
-
Safety and efficacy of e-cigarettes in those with atherosclerotic disease: a review.Open Heart. 2023 Dec 7;10(2):e002341. doi: 10.1136/openhrt-2023-002341. Open Heart. 2023. PMID: 38065586 Free PMC article. Review.
-
2023 TAMIS/TSOC/TACVPR Consensus Statement for Patients with Acute Myocardial Infarction Rehabilitation.Acta Cardiol Sin. 2023 Nov;39(6):783-806. doi: 10.6515/ACS.202311_39(6).20230921A. Acta Cardiol Sin. 2023. PMID: 38022422 Free PMC article.
-
Lipid-Lowering Therapy after Acute Coronary Syndrome in Outpatient Practice-How to Achieve Goal.J Clin Med. 2023 Oct 17;12(20):6579. doi: 10.3390/jcm12206579. J Clin Med. 2023. PMID: 37892717 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous